CITED4 gene silencing in colorectal cancer cells modulates adherens/tight junction gene expression and reduces cell proliferation

Area of Science:

• Molecular Biology
• Cancer Research
• Cell Biology

Background:

• CITED4 is a transcriptional cofactor implicated in various cancers, including colorectal cancer (CRC).
• Dysregulation of cofactor expression is a common feature in tumor development.
• Understanding CITED4's role is crucial for potential therapeutic strategies in CRC.

Purpose of the Study:

• To investigate the functional consequences of modulating CITED4 expression in colorectal cancer cells.
• To analyze the phenotypic and gene expression changes associated with CITED4 overexpression and knockdown.
• To identify specific molecular pathways affected by CITED4 in CRC cells.

Main Methods:

• Established CITED4-overexpressing and shRNA-knockdown SW480 colorectal cancer cell lines.
• Assessed cellular proliferation, apoptosis, cell cycle, migration, invasion, colony formation, and adhesion.
• Utilized microarray analysis for gene expression profiling and pathway analysis.
• Validated key gene expression changes using qRT-PCR and Western blotting.
• Examined actin cytoskeleton dynamics via phalloidin/vinculin staining.

Main Results:

• CITED4 overexpression in SW480 cells resulted in moderate adhesion changes.
• Knockdown of CITED4 led to decreased cell proliferation and G2 cell cycle arrest.
• Microarray analysis revealed deregulation of G protein-coupled receptors and genes associated with adherens and tight junctions (e.g., claudins, ezrin, MET, ß-catenin).
• No significant alterations in actin cytoskeleton morphology were observed.

Conclusions:

• CITED4 upregulation in SW480 cells did not induce an obvious phenotype.
• CITED4 knockdown significantly impacted cell proliferation and modulated numerous genes, including c-MET and adherens/tight junction components.
• These findings highlight CITED4's complex role in colorectal cancer, particularly its impact on cell cycle and junctional pathways.